ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bearishWuXi AppTec
31 Jul 2024 08:55

WuXi AppTec (2359.HK/603259.CH) 24H1- Backlog Looks Good but It May Not Bring a Performance Reversal

​WuXi AppTec aims to reassure investors in 24H1 report,highlighting resilience amid geopolitical risks.But US supply chain security is bipartisan...

Logo
273 Views
Share
bullishAlteogen Inc
31 Jul 2024 07:05

KRX New Deal Index Rebalance Preview: Potential Changes as Review Period Ends Today

We expect at least 1 change for each of the Secondary Battery, Bio, Internet, Game and BBIG indices. Flows are pretty big on some of the stocks and...

Logo
255 Views
Share
29 Jul 2024 07:05

KRX Foreign Holding Weekly (Jul 26th): Sk Hynix, Samsung Electronics

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Sk Hynix, Samsung Electronics.

Logo
201 Views
Share
23 Jul 2024 10:15

Sai Life Sciences Pre-IPO Tearsheet

SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.

Logo
273 Views
Share
22 Jul 2024 07:05

KRX Foreign Holding Weekly (Jul 19th): Samsung Heavy In, Samsung Electronics, Doosan Bobcat

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Heavy In, Sk Hynix, Samsung Electronics,...

Logo
217 Views
Share
x